TABLE 2.
LMHFV effects on osteoblasts.
| References | Cells | Frequency (Hz) | Magnitude (*g) | Time schedule | Main outcome |
| García-López et al., 2020 | Primary BALB/c mouse calvarial osteoblasts | 30 | 0.25 | 20 min/day | IL-4, IL-13, IL-17, OPG, TGF-β1 ↑ RANKL ↓ |
| Pravitharangul et al., 2018 | Osteoblast−like cells from iliac crest and mandibular bone specimens | 0, 30, 60 | 0.49 | 30 min/day | IL−6 mRNA expression ↑ IL−1β, RANKL mRNA ↓ RANKL/OPG ratio ↓ in iliac osteoblasts |
| Haffner-Luntzer et al., 2018b | MC3T3-E1 cells and primary C57BL/6 mouse osteoblasts | 45 | 0.3 | 20 min/day | Cytoskeletal remodeling: actin content, actin fiber thickness ↑ Cell metabolic activity, cell proliferation ↑ ERα signaling involved |
| Apa et al., 2018 | Osteoblast like cells (SaOS-2) | 30, 60, 90 | 0.3 1 3 | 1 h/day | Proliferation ↓ (0.3 g, 30 Hz) |
| Gao et al., 2017 | Primary osteoblasts | 45 | 0.5 | 1 h/day, 3 days | ALP, OCN, Runx2, BMP, OPG ↑ SOST ↓ Proliferation ↑ Matrix mineralization ↑ Cytoskeletal remodeling Wnt signaling involved |
| Ota et al., 2016 | MC3T3-E1 | 30, 60, 90 | 1.0–10 m/s2 | Runx2, Osterix, Col-1, ALP ↑ | |
| Rosenberg et al., 2002 | Samples of cancellous bone collected from femoral necks | 20, 30, 60 | 1.0–10 m/s2 | ALP ↑ (30–60 Hz) |